ERBB2 and thyroid gland carcinoma: Interestingly, we found a high homogeneity of MALDI-MSI maps, which indicated a generally low heterogeneity in the analyzed group of HER2-positive tumors (the intra-tumor similarity of MSI spectra was higher than in previously analyzed thyroid cancers [48]).